HOUSE_OVERSIGHT_025888.txt

This document discusses the FDA approval of a new cholesterol-lowering drug called Praluent, which is manufactured by Regeneron Pharmaceuticals. The article highlights the potential benefits and costs associated with this medication, as well as its impact on the battle against heart disease. Notable individuals mentioned in the document include Sultan Bin Sulayem, Jeffrey Epstein, Forbes Staff writer Matthew Herper, and Steven Nissen of the Cleveland Clinic.